Cargando…
Predictors of Treatment with Duloxetine or Venlafaxine XR among Adult Patients Treated for Depression in Primary Care Practices in the United Kingdom
Background. Knowledge about real-world use of duloxetine and venlafaxine XR to treat depression in the UK is limited. Aims. To identify predictors of duloxetine or venlafaxine XR initiation. Method. Adult depressed patients who initiated duloxetine or venlafaxine XR between January 1, 2006 and Septe...
Autores principales: | Shi, Nianwen, Durden, Emily, Torres, Amelito, Cao, Zhun, Happich, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375155/ https://www.ncbi.nlm.nih.gov/pubmed/22720149 http://dx.doi.org/10.1155/2012/815363 |
Ejemplares similares
-
Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007) -
Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder
por: Ye, Wenyu, et al.
Publicado: (2011) -
Depression Treatment with Duloxetine and Reduction of Inability to Work
por: Happich, Michael, et al.
Publicado: (2012) -
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisons
por: Eckert, Laurent, et al.
Publicado: (2006) -
A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal
por: Silva Miguel, Luís, et al.
Publicado: (2013)